Test Price
2,800 AED✅ Home Collection Available
ASAH1 Gene Sequencing for Farber Disease (Genetic Test) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل تسلسل جين ASAH1 لمرض فاربر في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Gold-standard NGS (Genetic Test guidance.
Executive Summary: This advanced genetic test utilises whole-gene NGS to identify pathogenic variants in ASAH1, enabling definitive diagnosis of Farber lipogranulomatosis, an autosomal recessive lysosomal storage disorder. Performed in our DHA‑licensed facility (Licence 9834453), results are delivered within 3‑4 weeks with pre‑ and post‑test genetic counselling included. Every step complies with Federal Decree‑Law No. 41 of 2024 (Art. 87), the UAE CDS Law 2026 for minors, and the UAE PDPL.
التحليل الجيني الكامل لجين ASAH1 باستخدام تقنية تسلسل الجيل التالي (NGS) يقدم تشخيصًا دقيقًا لمرض فاربر، وهو اضطراب أيضي وراثي نادر، معتمد من هيئة الصحة بدبي وبتوجيه من استشاريين معتمدين. يتم تقديم خدمة سحب العينات المنزلية بتقنية سلسلة التبريد المعتمدة ISO، مع ضمان الخصوصية الكاملة وفقًا لقانون حماية البيانات الشخصية في الإمارات.
- ✓ Accuracy: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139)
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection (ISO Certified Cold-Chain) and VIP Mobile Phlebotomy
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Competitive Edge
This test sequences all coding exons and flanking intronic regions of the ASAH1 gene using Genetic Test genetic counselling session is included to map the family pedigree.
| Feature | Our Test (NGS ASAH1 Full Gene) | Closest Alternative (Targeted Sanger Panel) |
|---|---|---|
| Methodology | NGS with CNV detection & full exon coverage | Sanger sequencing of known hotspots only |
| Diagnostic Yield | >99% for coding variants | ~85% (misses deep intronic/regulatory variants) |
| Turnaround Time | 3–4 weeks (with genetic counselling) | 4–6 weeks (without counselling) |
| UAE Regulatory Compliance | DHA licensed, PDPL compliant, minor consent per CDS Law 2026 | Variable; often lacks formal UAE consent framework |
Specimen Requirements & Pre‑Test Preparation
- Sample Types: Whole blood (EDTA tube), extracted DNA, or one drop of blood on an FTA card.
- Pre‑Test Mandatory: Clinical history, genetic counselling session to construct a pedigree of family members affected by Farber disease, and signed informed consent (guardian consent for minors under CDS Law 2026).
- Logistics: Home collection available 8 AM – 11 PM. Samples transported in ISO‑certified cold chain.
Physician Insight & Safety Protocol
“As a DHA-licensed consultant in clinical genomics, I emphasise that while a negative NGS result significantly reduces the likelihood of classic Farber disease, it does not entirely rule out atypical presentations or deep intronic variants not covered by the assay. Clinical correlation with biochemical markers and imaging remains essential. Please never stop prescribed enzyme replacement or supportive therapies without direct consultation.”
– Dr. PRABHAKAR REDDY, DHA Licence 61713011
Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & Safety Red Flags
- Inability to provide informed consent or guardian consent (minors).
- Known haematological instability precluding safe phlebotomy (e.g., severe anaemia, active bleeding disorder).
- Emergency Red Flags: If the patient develops acute respiratory distress, severe joint contractures with pain, or neurological deterioration, seek immediate emergency care – do not wait for test results.
Patient FAQ & Clinical Guidance
1. What does the ASAH1 NGS test detect, and how is it different from a standard metabolic screen?
The identifies disease-causing variants in the entire ASAH1 gene, offering a definitive molecular diagnosis of Farber disease rather than only biochemical suspicion.
يكتشف هذا التحليل الطفرات المسببة للمرض في كامل جين ASAH1، مما يوفر تشخيصًا جزيئيًا نهائيًا لمرض فاربر بدلاً من الاكتفاء بالمؤشرات الكيميائية الحيوية.
2. Is genetic counselling mandatory, and how does it help my family?
Yes, a DHA-mandated counselling session maps the inheritance pattern, identifies at‑risk relatives, and supports future reproductive options.
نعم، جلسة الاستشارة الوراثية إلزامية بموجب هيئة الصحة بدبي، حيث ترسم نمط الوراثة وتحدد الأقارب المعرضين للخطر وتدعم الخيارات الإنجابية المستقبلية.
3. How private is my genetic data under UAE law?
Your genomic information is protected under the UAE PDPL, processed only in DHA-licensed facilities, and never shared without explicit consent.
معلوماتك الجينية محمية بموجب قانون حماية البيانات الشخصية في الإمارات، وتُعالج فقط في منشآت مرخصة من هيئة الصحة بدبي ولا تُشارك دون موافقة صريحة.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians